Novoeight

Novo Nordisk Hemophilia and Rare Bleeding Disorder Product Assistance Program Patient Guide: How to Get Novoeight at Low or No Cost

About This Program

The Novo Nordisk Hemophilia and Rare Bleeding Disorder Product Assistance Program (PAP) provides Novoeight (turoctocog alfa) at no charge to eligible patients who meet specific financial and insurance criteria. Novoeight is a recombinant clotting factor replacement therapy used to control and prevent bleeding episodes in people with hemophilia A. This guide explains how to apply and what to expect.

About Novoeight

Novoeight is an injectable medicine containing turoctocog alfa, a lab-made version of clotting factor VIII. People with hemophilia A have a deficiency in this clotting factor, which puts them at risk for excessive and prolonged bleeding. Novoeight works by replacing the missing or non-functioning factor VIII, helping blood form clots properly. It can be used to:

• Control and prevent bleeding episodes
• Manage bleeding during surgery
• Reduce the frequency of bleeding episodes through preventive treatment

Your healthcare provider will determine the appropriate dosing schedule based on your specific condition and needs.

Who Qualifies for This Program

To be eligible for the Novo Nordisk PAP, you must meet all of the following requirements:

Basic Eligibility

• U.S. Citizenship or Legal Residency: You must be a U.S. citizen or legal resident
• Hemophilia A Diagnosis: You have been prescribed Novoeight by a healthcare provider for an FDA-approved indication
• No Prescription Drug Coverage: You do not have prescription coverage through an HMO, PPO, or similar commercial insurance plan

Income Requirements

Your total household income must be at or below 400% of the federal poverty level. The federal poverty level changes annually, so your eligibility may change from year to year.

2024 Federal Poverty Level Guidelines (400% threshold):

Note: These figures are based on 2024 guidelines. Contact the program for current year thresholds.

Insurance Restrictions

You are NOT eligible if you:

• Have commercial insurance (HMO or PPO)
• Participate in or receive reimbursement from federal or state healthcare programs with prescription drug coverage, including:
  • Medicaid
  • Medicare
  • Medigap
  • Veterans Affairs (VA)
  • Department of Defense (DOD)
  • TRICARE
  • Any similar federal or state health care program

How to Apply

Step 1: Gather Required Documents

Before applying, collect the following:

• Proof of Residency: A recent utility bill, lease agreement, or government-issued ID showing your current address
• Proof of Income: Recent pay stubs, tax returns, Social Security statements, or other documentation of household income
• Prescription: A valid prescription for Novoeight from your healthcare provider

Step 2: Contact the Program

Call the Novo Nordisk assistance line at 1-844-668-6732 to speak with a NovoCare Specialist. They will:

• Answer your eligibility questions
• Help you understand the application process
• Provide you with an application form
• Guide you through submission

Step 3: Complete and Submit Your Application

Fill out the Novo Nordisk Product Assistance Application completely and accurately. Include all required documentation. You can submit your application by mail to the address provided by the NovoCare Specialist.

Step 4: Wait for Approval

The program typically processes applications within 2 business days. You will be notified of your approval or denial status.

Step 5: Receive Your Medication

Once approved, your prescribed dose of Novoeight will be shipped directly to your home address at no cost to you.

Important Restrictions

When receiving free Novoeight through this program:

• You cannot bill any third party (insurance, government programs, or other entities) for the free product
• You cannot resell the free product
• Violation of these restrictions may result in program termination

Timeline and What to Expect

What If Your Application Is Denied?

If you don't qualify for the PAP, you have other options:

• Trial Prescription Program: Qualifying patients with commercial insurance may receive a limited trial supply of 6 doses of Novoeight at no cost. Call 1-844-668-6732 for details.
• Co-pay Assistance Program: If you have commercial insurance, Novo Nordisk offers co-pay assistance to help reduce your out-of-pocket costs.
• Medicare/Medicaid Programs: Contact your state Medicaid office or Medicare to learn about prescription drug coverage options.
• Patient Advocacy Organizations: Hemophilia organizations may offer additional resources or financial assistance programs.

Reauthorization

Your assistance through this program requires periodic reauthorization. You will need to reapply and resubmit documentation to continue receiving free Novoeight. The program will notify you when reauthorization is required.

Important Disclaimer

This guide provides general information about the Novo Nordisk Hemophilia and Rare Bleeding Disorder Product Assistance Program. Program eligibility, requirements, and benefits may change at any time. For the most current and accurate information, contact the program directly at 1-844-668-6732 or speak with your healthcare provider. This guide is not a guarantee of eligibility or approval.

Contact Information

Novo Nordisk Patient Assistance Program Phone: 1-844-668-6732 Available to speak with NovoCare Specialists who can answer your questions and help with your application.